From: Postpartum diabetes screening among low income women with gestational diabetes in Missouri 2010–2015
Prenatal healthcare utilization | Median (IQR) or n (%) |
Oral hypoglycemic medicine prescribed during pregnancy | 108 (10.0) |
Insulin prescribed during pregnancy | 27 (2.5) |
Total visits during prenatal period a | 11.5 (7–16) |
Time from first prenatal visit to delivery (weeks) (n = 1065) | 29.7 (23.0–33.1) |
Women with ≥ one prenatal CDE visits | 130 (12.1) |
Women with no medical records available prior to prenatal record | 395 (36.6) |
Postpartum maternal healthcare utilizationb | Median (IQR) or n (%) |
Total visits within one year postpartum a | 3 (1–5) |
Women with at least one visit in first 12 weeks postpartum a | 787 (73.0) |
Women with at least one visit in the first postpartum year a | 904 (83.9) |
Postpartum data available for ≥ one year | 672 (62.3) |
Length of follow-up for whole population (years) c | 1.2 (0.3–2.5) |
Length of follow-up for individuals with > one year of data (years) c | 2.1 (1.3–3.3) |